181 related articles for article (PubMed ID: 37950135)
21. A review on JC virus infection in kidney transplant recipients.
Delbue S; Ferraresso M; Ghio L; Carloni C; Carluccio S; Belingheri M; Edefonti A; Ferrante P
Clin Dev Immunol; 2013; 2013():926391. PubMed ID: 23424601
[TBL] [Abstract][Full Text] [Related]
22. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
Bauer J; Gold R; Adams O; Lassmann H
Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of progressive multifocal leukoencephalopathy--revisited.
White MK; Khalili K
J Infect Dis; 2011 Mar; 203(5):578-86. PubMed ID: 21227915
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathy.
Ferrante P; Caldarelli-Stefano R; Omodeo-Zorini E; Cagni AE; Cocchi L; Suter F; Maserati R
J Med Virol; 1997 Jul; 52(3):235-42. PubMed ID: 9210030
[TBL] [Abstract][Full Text] [Related]
25. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
26. Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab.
Boesl F; Allers K; Herm J; Scheider T; Franke C
J Neurovirol; 2022 Apr; 28(2):335-338. PubMed ID: 35320511
[TBL] [Abstract][Full Text] [Related]
27. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
28. Fatal progressive multifocal leukoencephalopathy in a kidney transplant recipient 19 years after successful renal allograft transplantation.
Carlson N; Hansen JM
Transplant Proc; 2014 Sep; 46(7):2403-5. PubMed ID: 24998303
[TBL] [Abstract][Full Text] [Related]
29. Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy.
Hammarin AL; Bogdanovic G; Svedhem V; Pirskanen R; Morfeldt L; Grandien M
J Clin Microbiol; 1996 Dec; 34(12):2929-32. PubMed ID: 8940424
[TBL] [Abstract][Full Text] [Related]
30. JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.
Delbue S; Elia F; Carloni C; Tavazzi E; Marchioni E; Carluccio S; Signorini L; Novati S; Maserati R; Ferrante P
J Cell Physiol; 2012 Oct; 227(10):3511-7. PubMed ID: 22253012
[TBL] [Abstract][Full Text] [Related]
31. Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy.
Wüthrich C; Koralnik IJ
J Neuropathol Exp Neurol; 2012 Jan; 71(1):54-65. PubMed ID: 22157619
[TBL] [Abstract][Full Text] [Related]
32. Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.
Verhelst X; Vanhooren G; Vanopdenbosch L; Casselman J; Laleman W; Pirenne J; Nevens F; Orlent H
Transpl Int; 2011 Apr; 24(4):e30-4. PubMed ID: 21134241
[TBL] [Abstract][Full Text] [Related]
33. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
[TBL] [Abstract][Full Text] [Related]
34. Long-term Survival in a Kidney Transplantation Patient With Progressive Multifocal Leukoencephalopathy: A Case Report.
Mochizuki T; Teranishi J; Takamoto D; Ohtaka M; Kawahara T; Makiyama K; Uemura H
Transplant Proc; 2018 Oct; 50(8):2558-2561. PubMed ID: 30316398
[TBL] [Abstract][Full Text] [Related]
35. Progressive multifocal leukoencephalopathy: clinical and molecular aspects.
Tavazzi E; White MK; Khalili K
Rev Med Virol; 2012 Jan; 22(1):18-32. PubMed ID: 21936015
[TBL] [Abstract][Full Text] [Related]
36. Progressive multifocal leukoencephalopathy: why gray and white matter.
Gheuens S; Wüthrich C; Koralnik IJ
Annu Rev Pathol; 2013 Jan; 8():189-215. PubMed ID: 23092189
[TBL] [Abstract][Full Text] [Related]
37. Immune surveillance and response to JC virus infection and PML.
Beltrami S; Gordon J
J Neurovirol; 2014 Apr; 20(2):137-49. PubMed ID: 24297501
[TBL] [Abstract][Full Text] [Related]
38. Early reduction of the splicing factor2/alternative splicing factor: a cellular inhibitor of the JC polyomavirus in natalizumab-treated MS patients long before developing progressive multifocal leukoencephalopathy.
Piu C; Ibba G; Bertoli D; Capra R; Uleri E; Serra C; Imberti L; Dolei A
J Neurovirol; 2020 Feb; 26(1):133-137. PubMed ID: 31468472
[TBL] [Abstract][Full Text] [Related]
39. Progressive Multifocal Leukoencephalopathy in Children with Primary and Secondary Immune Deficiency.
Demirbuğa A; Kaba O; Törün SH; Yıldız EP; Yücel E; Somer A
Pediatr Allergy Immunol Pulmonol; 2021 Sep; 34(3):109-111. PubMed ID: 34142853
[TBL] [Abstract][Full Text] [Related]
40. JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?
Diotti RA; Nakanishi A; Clementi N; Mancini N; Criscuolo E; Solforosi L; Clementi M
Clin Dev Immunol; 2013; 2013():967581. PubMed ID: 23878587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
